Breathe Well Live Well
Lung Disease News |
COPD, Asthma Treatment Aided By Computerized Clinical Decision Support …
Lung Disease News However, despite CCDSS use in a variety of diseases, its systematic impact on the clinical assessment of chronic respiratory diseases, such as asthma and COPD, is still lacking. In this new research, the authors performed a systematic review to present … |
View full post on asthma – Google News
Condition: Asthma
Intervention: Other: Asthma Shared Decision Making (SDM) Toolkit
Sponsor: Carolinas Healthcare System
Enrolling by invitation – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Dismay at decision over asthma drug
Bradford Telegraph and Argus An asthma drug which has transformed the lives of patients in Bradford could be withdrawn from the NHS. Doctors and charities have spoken of their dismay at a decision by the National Institute for Health and Clinical Excellence (Nice), which has … |
View full post on asthma – Google News
|
Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News … in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease. Mylan to fight $18M patent infringement ruling |
View full post on asthma – Google News
 Center For American Progress |
Disappointing smog decision
Chicago Tribune Exposure to smog triggers asthma attacks, causes permanent lung damage, and can even lead to premature death. In Illinois alone, almost 250000 children experience asthma attacks and over 700000 adults experience attacks every year. … Oppose Bills That Repeal Health Safeguards Against Mercury Pollution |
View full post on asthma – Google News
 Daily Mail |
Charity angry at NICE decision on Xolair
OnMedica Omalizumab is licensed as add-on therapy for adults and children aged at least 6 years, who have severe persistent allergic asthma and meet other criteria. … Asthma drug denied to young children UK's NICE reaffirms decision to deny use of Novartis' asthma drug Xolair for … Under-12s to be denied asthma jab only if they live in England |
View full post on asthma – Google News
 ITN |
Asthma drug decision 'nonsensical'
The Press Association The health watchdog has been accused of being "nonsensical" for denying young children with severe asthma access to a drug. The National Institute for … UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11 |
View full post on asthma – Google News
Jazz Repaying Debt Ahead of Fibromyalgia Drug Decision
Jazz Pharmaceuticals Inc. is raising about $58.5 million in a public offering to pay off a sizeable chunk of its outstanding debt ahead of an FDA decision on fibromyalgia drug JZP-6 (sodium oxybate), expected this fall.
Read more on BioWorld